Marketing Access
Market access focuses on ensuring that approved ATMPs can reach the patients who need them. This involves working with healthcare providers, payers, and other stakeholders to support the adoption and implementation of the therapy in clinical practice. Activities may include establishing treatment pathways, ensuring manufacturing and supply capabilities, and addressing practical challenges related to the delivery of advanced therapies. The goal is to enable timely and sustainable patient access to innovative treatments.
AstraZeneca
AstraZeneca is global pharma company with strong connection to Sweden through both big research and manufacturing sites. Their development of ATMPs includes CAR-T and TCR-T treatments, as well as drug delivery platforms. Their research as well as product development is spread out globally with over 80 000 employees over the world.